← Back to Clinical Trials
Recruiting NCT07464379
Basic and Clinical Research of Pregnancy-Induced Hypertension
◆ AI Clinical Summary
Plain-language summary for patients
Trial Parameters
Condition Pregnancy-induced Hypertension
Sponsor Second Affiliated Hospital of Wenzhou Medical University
Study Type OBSERVATIONAL
Phase N/A
Enrollment 100
Sex FEMALE
Min Age 20 Years
Max Age 50 Years
Start Date 2020-01-01
Completion 2027-12-31
Interventions
no Intervention
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
Brief Summary
Collect blood pressure, blood, amniotic fluid, placenta and other samples from normal pregnant women, patients with pregnancy-induced hypertension and those who have experienced miscarriage, and conduct tests on them.
Eligibility Criteria
Inclusion Criteria: \- Healthy pregnant women, patients with miscarriage, etc. Exclusion Criteria: * Heart disease, infections, etc. in pregnant women Uncooperative patients
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology